Evaluation of Previously Assigned Antibody Concentrations in Pneumococcal Polysaccharide Reference Serum 89SF by the Method of Cross-Standardization
- 1 March 1998
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 5 (2) , 199-204
- https://doi.org/10.1128/cdli.5.2.199-204.1998
Abstract
An enzyme-linked immunosorbent assay (ELISA) and the antibody concentrations assigned to different pneumococcal capsular polysaccharide types were used to estimate concentrations of antibody to additional pneumococcal types in reference serum 89SF and to confirm assigned antibody values. This was possible because the slopes of curves of antibody binding to all polysaccharide types evaluated (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F) were similar. The point estimates for total anti-pneumococcal antibody and immunoglobulin G (IgG) antibody determined by cross-standardization by an ELISA based on use of methylated human serum albumin (mHSA) to improve the efficiency of polysaccharide binding to the ELISA plate differed by less than 40% from those reported by Quataert et al. (Clin. Diagn. Lab. Immunol. 2:590–597, 1995) for types 1, 4, 6B, 7F, 9V, 14, 18C, and 23F. However, large differences were found between the assigned values and those obtained by our mHSA ELISA for types 3 and 19F. The mHSA ELISA and the direct polysaccharide coat ELISA may not measure antibodies to the same epitopes on polysaccharides of types 3 and 19F. The functional importance of these different antibody specificities is being investigated. We have thus confirmed the assigned IgG antibody values for most types by a different method and have extended antibody assignments to several additional types.Keywords
This publication has 14 references indexed in Scilit:
- Epidemiology of Invasive Pneumococcal Disease in Southern California: Implications for the Design and Conduct of a Pneumococcal Conjugate Vaccine Efficacy TrialThe Journal of Infectious Diseases, 1996
- IMMUNOGENICITY AND SAFETY OF 7-VALENT PNEUMOCOCCAL-CRM197 CONJUGATE VACCINE. ▴ 1082Pediatric Research, 1996
- A Modified Farr Assay Is More Specific than ELISA for Measuring Antibodies to Streptococcus pneumoniae Capsular PolysaccharidesThe Journal of Infectious Diseases, 1996
- Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-SClinical and Diagnostic Laboratory Immunology, 1995
- Evaluation of Bacterial Polysaccharide Immune Globulin for the Treatment or Prevention of Haemophilus influenzae Type b and Pneumococcal DiseaseThe Journal of Infectious Diseases, 1992
- Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methodsMicrobial Pathogenesis, 1990
- Antibody Response of Adults to an Aluminum Hydroxide-Adsorbed Neisseria meningitidis Serotype 2b Protein-Group B Polysaccharide VaccineThe Journal of Infectious Diseases, 1988
- Serum antibodies to pneumococcal C polysaccharide in childrenThe Pediatric Infectious Disease Journal, 1987
- Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide VaccineNew England Journal of Medicine, 1984
- Assessment of the Antibody Response to Pneumococcal Vaccine in High-Risk PopulationsClinical Infectious Diseases, 1981